NeoCore Technology Co., Ltd. (TPEX:4131)

Market Cap	1.43B +13.5%
Revenue (ttm)	244.66M +297.5%
Net Income	-30.87M
EPS	-0.78
Shares Out	39.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	117,001
Average Volume	80,201
Open	35.20
Previous Close	35.20
Day's Range	34.00 - 36.10
52-Week Range	28.80 - 42.45
Beta	-0.36
RSI	41.12
Earnings Date	Mar 13, 2026

About NeoCore Technology

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and cha...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1987
• Employees: 44
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4131

Financial Performance

In 2025, NeoCore Technology's revenue was 244.66 million, an increase of 297.52% compared to the previous year's 61.55 million. Losses were -30.87 million, -35.87% less than in 2024.